For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Shire-Nps Pharmaceuticals, Inc.

USPTO Granted Patents = 19

% Expired Patents = 15.8

Trademarks = 7

Forward Citations = 1

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Thomas B Marriott (18 out of 25 patents)

Jennifer Lopansri (18 out of 24 patents)

Consuelo M Blosch (18 out of 24 patents)

4. Elizabeth Lemaire Sanguinetti (18 out of 24 patents)

5. Kevin Holmes (1 out of 6 patents)

6. Angela Norton (1 out of 13 patents)

7. Clark Qun Pan (1 out of 56 patents)

8. Rongxin Shi (1 out of 2 patents)

9. Bryan James Goodwin (1 out of 1 patent)

10. David Bruce Lloyd (1 out of 1 patent)

11. Chuan Shen (1 out of 3 patents)

12. Sujit Jain (1 out of 2 patents)

19 patents: Sort by Forward Citations

1. 11634468 - Parathyroid hormone variants (2023-04-25),

2. 9999656 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-19),

3. 9993528 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-12),

4. 9987335 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-05),

5. 9987334 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-05),

6. 9981016 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

7. 9981015 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

8. 9981014 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

9. 9974838 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

10. 9974837 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

11. 9974836 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

12. 9974835 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

13. 9968658 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

14. 9968657 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

15. 9968656 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

Company Overview

Shire-NPS Pharmaceuticals, Inc., based in Lexington, MA, specializes in developing innovative therapies for rare diseases. The company focuses on addressing unmet medical needs through advanced research and development in biopharmaceuticals. Its portfolio includes treatments for conditions related to gastrointestinal, endocrine, and central nervous system disorders. By leveraging cutting-edge technology and scientific expertise, Shire-NPS aims to improve the quality of life for patients facing complex health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#38 in Lexington, MA

#1,049 in Massachusetts

#17,150 in US

#32,693 in the World

Lexington, MA, United States of America

Shire-Nps Pharmaceuticals, Inc.

Forward Citations = 1

12 inventors:

Thomas B Marriott (18 out of 25 patents)

Jennifer Lopansri (18 out of 24 patents)

Consuelo M Blosch (18 out of 24 patents)

4. Elizabeth Lemaire Sanguinetti (18 out of 24 patents)

5. Kevin Holmes (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shire-Nps Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/shire-nps-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…